Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
131 | Alaska Air Group Inc (ALK) | XNYS | US | 2024-12-31 | 1 day ago | USD | 50.88 | 37.78 | 74.26% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
132 | Accenture PLC (ACN) | XNYS | IE | 2024-08-31 | 1 day ago | USD | 302.29 | 105.66 | 34.95% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
133 | ACNB Corp (ACNB) | XNAS | US | 2024-12-31 | 1 day ago | USD | 44.23 | 55.51 | 125.51% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 1 day ago | USD | 4.92 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
136 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 1 day ago | USD | 1.45 | 0.00 | 0.00% | 0.57 | 39.12% | Ungraded | 0.00 | 0.00% |
137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 1 year ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
138 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 1 day ago | USD | 3.74 | 0.00 | 0.00% | 1.86 | 49.71% | Ungraded | 0.00 | 0.00% |
139 | ALLETE Inc (ALE) | XNYS | US | 2024-12-31 | 1 day ago | USD | 64.77 | 63.06 | 97.37% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 1 day ago | USD | 0.24 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |